Literature DB >> 6372482

Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections.

C E Nord, L Kager, A Heimdahl.   

Abstract

The most common and significant cause of disturbances in the normal gastrointestinal microflora is the administration of antimicrobial agents. The microflora can be influenced by antimicrobial agents because of incomplete absorption of any orally administered antimicrobial agent, secretion of an antimicrobial agent by the salivary glands and in the bile, or secretion from the intestinal mucosa. In most cases the influence is not beneficial to the patient because suppression of the indigenous microorganisms often permits potential pathogens to overgrow and cause septic conditions, diarrhea, or colitis. Antimicrobial agents that influence the normal microflora also promote the emergence of antimicrobial-resistant strains. The authors' experience on the impact of different beta-lactams, erythromycin, clindamycin, tetracycline, and nitroimidazoles on the gastrointestinal microflora and the risk of infections when these agents are used is reviewed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6372482     DOI: 10.1016/0002-9343(84)90250-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  39 in total

1.  P1A recombinant beta-lactamase prevents emergence of antimicrobial resistance in gut microflora of healthy subjects during intravenous administration of ampicillin.

Authors:  Ann-Mari Tarkkanen; Tuula Heinonen; Rain Jõgi; Silja Mentula; Michel E van der Rest; Curtis J Donskey; Tuomas Kemppainen; Konstantin Gurbanov; Carl Erik Nord
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191

2.  Reply to "Are there reasons to prefer tetracyclines to macrolides in older patients with community-acquired pneumonia?".

Authors:  Kevin A Brown; Nagham Khanafer; Nick Daneman; David N Fisman
Journal:  Antimicrob Agents Chemother       Date:  2013-08       Impact factor: 5.191

3.  Effect of lomefloxacin on the normal oral and intestinal microflora.

Authors:  C Edlund; B Brismar; C E Nord
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-01       Impact factor: 3.267

4.  Canadian practice guidelines for surgical intra-abdominal infections.

Authors:  Anthony W Chow; Gerald A Evans; Avery B Nathens; Chad G Ball; Glen Hansen; Godfrey Km Harding; Andrew W Kirkpatrick; Karl Weiss; George G Zhanel
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

5.  Recurrent urinary tract infections in healthy and nonpregnant women.

Authors:  Matthew Glover; Cristiano G Moreira; Vanessa Sperandio; Philippe Zimmern
Journal:  Urol Sci       Date:  2014-03

6.  Alleviating cancer drug toxicity by inhibiting a bacterial enzyme.

Authors:  Bret D Wallace; Hongwei Wang; Kimberly T Lane; John E Scott; Jillian Orans; Ja Seol Koo; Madhukumar Venkatesh; Christian Jobin; Li-An Yeh; Sridhar Mani; Matthew R Redinbo
Journal:  Science       Date:  2010-11-05       Impact factor: 47.728

7.  Beta-lactamase production by oral anaerobic gram-negative species in infants in relation to previous antimicrobial therapy.

Authors:  S Nyfors; E Könönen; A Takala; H Jousimies-Somer
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

8.  Effect of enoxacin on colonic microflora of healthy volunteers.

Authors:  C Edlund; A Lidbeck; L Kager; C E Nord
Journal:  Eur J Clin Microbiol       Date:  1987-06       Impact factor: 3.267

9.  Effect of aztreonam on the colon microflora in patients undergoing colorectal surgery.

Authors:  L Kager; B Brismar; A S Malmborg; C E Nord
Journal:  Infection       Date:  1985 May-Jun       Impact factor: 3.553

Review 10.  Host response to Clostridium difficile infection: Diagnostics and detection.

Authors:  Elena A Usacheva; Jian-P Jin; Lance R Peterson
Journal:  J Glob Antimicrob Resist       Date:  2016-09-20       Impact factor: 4.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.